DGAP-News: Apricus Biosciences Announces That Its NexACT(R) Partner Exodos Life Sciences Has Completed Its pre-IND Meeting With the FDA
Apricus Biosciences, Inc.
15.11.2011 15:30
—————————————————————————
Exodos Moves Closer to Filing a U.S. Investigational New Drug Application for
Its Topically-Applied Formulation of Ketoprofen for Pain Relief
SAN DIEGO, 2011-11-15 15:30 CET (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
announced today that its NexACT(r) out-licensing partner, Exodos Life Science
Limited Partnership (–Exod
